23andMe to cut 40% of workforce, end therapeutics program
Genetic-testing lab 23andMe plans to cut its workforce by 40% and end its therapeutics program in an effort to cut costs, the company announced Monday.
23andMe Cuts 40% of Its Workforce and Discontinues Therapeutics Division
Me is laying off 40% of its workforce, or more than 200 employees, and discontinuing its therapeutics division as the struggling genetic testing company attempts to slash costs
23andMe to Cut 40% of Its Staff Amid Grim Financials
The DNA testing kit company is also discontinuing new developments to its therapeutics program, which has been focused on using customers’ DNA data to aid in drug discovery.
23andMe Lays Off 40 Percent of its Staff, Ends All Therapy Programs
As founder and CEO Anne Wojcicki struggles to take the company private, 200 jobs are cut as part of its restructuring plan.
23andMe lays off 40% of its workforce, ends therapeutics division
Me is laying off 40 per cent of its workforce, or more than 200 employees, and discontinuing its therapeutics division as the struggling genetic testing company attempts to slash costs.
23andMe to lay off 40% of its workforce as stock price plummets
The genetic testing company 23andMe is cutting 40% of its workforce and ending its therapeutics program as its stock price continues to plummet. CBS News correspondent Carter Evans has more on what this means for its customers.
23andMe Lays Off 40% of Its Workforce as Company Spirals
The genetic testing company 23andMe announced it was laying off more than 200 employees, or roughly 40% of its entire workforce, according to a press release Monday. The move is part of a restructuring that will see the company also halt the development of its therapeutics division which had been working on various potential medical treatments.
Genetic Discrimination Is Coming for Us All
The familial trend, it turned out, was linked to a genetic mutation. That meant Bill might also be at risk for the disease.
CNET on MSN1d
With 23andMe Struck by Layoffs, Can You Delete Genetic Data? Here's What We Know
In the wake of a big data breach and a sizable new round of layoffs, 23andMe's handling of sensitive personal data is in the ...
Crain's Chicago Business8d
Tempus buying genetics lab company for $600 million
With Ambry Genetics in tow, Eric Lefkofsky's biotech startup hopes to accelerate its drive toward turning a profit.
Orange County Business Journal4d
Tempus AI to Buy Ambry Genetics for $600M
Ambry’s Secret Sauce Ambry Genetics, founded in 1999 by Charles Dunlop, became known for several innovations, such as the ...
CNN on MSN6d
Workers found human bones by Hoover Dam in 2009. 15 years later, officials identified the John Doe
In 2009, two construction workers found human bones on a highway near the historic Hoover Dam. Thanks to forensic genetic ...
360dx8d
Owners of Lab, Marketing Firms Convicted of Multimillion-Dollar Genetic Testing Fraud Scheme
Fadel Alshalabi, owner and CEO of Crestar Labs, and Samuel Harris, owner of Flojo Recruiting, conspired to bill Medicare and Medicaid for millions of dollars in genetic test orders.
UC San Francisco11h
1 Genomic Test Can Diagnose Nearly Any Infection
A decade-long effort has resulted in a new, rapid genomic test to diagnose rare infectious diseases in the brain and lungs.
Myriad Genetics Expands Access to At-Home Early Fetal Sex DNA Test with Retail Launch
Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, continues to empower parents with increased access to prenatal testing. SneakPeek, the #1 OBGYN-recommended ...
The Associated Press on MSN4d
Monkeys that escaped a lab are a species used for human research since the 1800s
The rhesus macaque monkeys that escaped a South Carolina medical lab this week are among the most studied animals on the planet ...
Bioluminescent sea slug discovered in the deep sea swims through the ocean's midnight zone
MBARI researchers have discovered a remarkable new species of sea slug that lives in the deep sea. Bathydevius caudactylus ...
News Medical on MSN2d
New genetic model offers insights into breast cancer metastasis
A Michigan State University researcher's new model for studying breast cancer could help scientists better understand why and where cancer metastasizes.